You are here: Industry Insights > COVID-19

News List

NICE publishes second set of rapid COVID-19 guidelines pharmatimes
April 02, 2020
The National Institute for Health and Care Excellence (NICE) has published its second set of rapid guidelines to cover the provision of radiotherapy services and bone marrow transplant during the COVID-19 pandemic.
Positive early data from siltuximab COVID-19 trial pharmatimes
April 02, 2020
A third of patients with COVID-19 taking EUSA Pharma's interleukin (IL)-6 targeted monoclonal antibody siltuximab have experienced a clinical improvement, according to early findings from an observational case-control trial in Italy.
Aptorum to investigate use of repurposed drug candidates for coronavirus pharmaceutical-business-review
April 02, 2020
Aptorum Group has joined forces with Covar Pharmaceuticals for studying the use of three repurposed drug candidates for the treatment of novel coronavirus (COVID-19).
Beckman Coulter Announces Test Development for Coronavirus Antibodies americanpharmaceuticalreview
April 02, 2020
In response to the global COVID-19 pandemic, Beckman Coulter is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2.
FibroGenesis Files Expanded Patent Coverage for Fibroblast Cell Therapy for COVID-19 ARDS americanpharmaceuticalreview
April 02, 2020
FibroGenesis announced the filing of United States Provisional Patent Number 63/002,134 titled, "Peptides and Adjuvants for Augmentation of Fibroblast Therapy for Coronavirus."
FDA and EMA offer updates on COVID-19 treatments and vaccines in development europeanpharmaceuticalreview
April 02, 2020
The FDA and EMA have announced which COVID-19 treatments and vaccines are currently in development, as well as how they are supporting clinical trials.
Accord to donate four million tablets to global COVID-19 prophylaxis trial europeanpharmaceuticalreview
April 02, 2020
The enterprise announced it will donate two million hydroxychloroquine tablets and the same of matched placebo to the multi-national COPCOV study.
How to take care of your mental health during the COVID-19 pandemic europeanpharmaceuticalreview
April 02, 2020
During the COVID-19 pandemic, when many are in lockdown or self-isolating, mental health could suffer. This article suggests some ways to stay healthy over this period.
FDA launches new programme to speed-up Covid-19 therapies pharmaceutical-technology
April 02, 2020
The US Food and Drug Administration (FDA) has launched a new programme aimed at accelerating the development of potential treatments for Covid-19 infection.
Neurimmune and Ethris to develop mRNA antibody for Covid-19 pharmaceutical-technology
April 02, 2020
Swiss biopharmaceutical firm Neurimmune has partnered with German biotechnology company Ethris to develop mRNA-based, neutralising antibodies for a Covid-19 therapeutic formulated for inhalation.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page